Life Science Investor Relations Forum 2017 | EXL Events | 7 September 2017 | Revere Hotel Boston Common, 200 Stuart St, Boston, Massachusetts 02116

The Life Science Investor Relations Forum, taking place on September 7—8, 2017 in Boston, will bring together IR professionals to address the diverse set of challenges faced in the life sciences industry. Our expert speaking faculty will provide thought-provoking dialogue paired with networking opportunities that no other conferences address. IR teams are continuously balancing new regulations, advancements in technology, more engaged investors and working relationships with advisory boards. Through this event IR specialists will be able to efficiently gain the knowledge they need to improve their programs while developing a new network of educated IR colleagues. At this breakthrough, two-day conference we will provide our attendees with the solutions to the unique set of challenges IR teams encounter and enable them to be more effective in their jobs.

Paul Cox,
Senior Director, Investor Relations,
Sage Therapeutics

Seth Lewis,
Vice President Investor Relations,
Bavarian Nordic A/S

Salim Syed,
Managing Director,
Senior Biotechnology Analyst,
Head of Biotechnology Research,
Mizuho Securities USA

Felicia Vonella,
Executive Director,
Investor Relations,
Acorda Therapeutics

Elif McDonald,
Director,
Investor Relations,
Valeant Pharmaceuticals

Manisha Pai,
Head of Investor Relations and Corporate Communications,
Bluebird Bio

Michelle Linn,
Vice President Corporate Communications, Agenus